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OBJECTIVE — Tocomparethediagnosticcharacteristicsoftestsusedforapromptdiagnosis
of chronic osteomyelitis in the diabetic foot, using bone histology as the criterion standard. The
tests assessed were probe-to-bone (PTB), clinical signs of infection, radiography signs of osteo-
myelitis, and ulcer specimen culture.
RESEARCH DESIGN AND METHODS — A prospective study was performed on pa-
tients with foot ulcers referred to our diabetic foot clinic. Ulcer infection was diagnosed by
recordingclinicalsignsofinfectionandtakingspecimensforculture.Thepresumptivediagnosis
of osteomyelitis was based on these results and the ﬁndings of a plain X-ray and PTB test. All
patients with a clinical suspicion of bone infection were subjected to surgical treatment of the
affected bone. During surgery, bone specimens were obtained for a histological diagnosis of
osteomyelitis.
RESULTS — Over 2.5 years, 210 foot lesions were consecutively examined and 132 of these
wounds with clinical suspicion of infection selected as the study sample. Of these, 105 (79.5%)
lesionswerediagnosedasosteomyelitis.Amongthetestscompared,thebestresultswereyielded
by the PTB test including an efﬁciency of 94%, sensitivity of 98%, speciﬁcity of 78%, positive
predictivevalueof95%,andnegativepredictivevalueof91%(P0.001,0.803);thepositive
likelihood ratio was 4.41, and the negative likelihood ratio was 0.02 (95% CI).
CONCLUSIONS — In our outpatient population with a high prevalence of osteomyelitis,
the PTB test was of greatest diagnostic value, especially for neuropathic ulcers, and proved to be
efﬁcient for detecting osteomyelitis in the diabetic foot.
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I
n Spain, amputations due to osteomy-
elitisareperformedeachyearin46.1of
every 100,000 individuals with diabe-
tes (1). In diabetic patients, approxi-
mately two-thirds of all amputations are
preceded by the infection of a foot ulcer
(2–4). However, the diagnosis of chronic
osteomyelitis in the diabetic foot contin-
ues to be a challenge, and we believe that
there is a need for more studies validating
the different diagnostic methods avail-
able. There is also a clear need for a safe,
rapid, and efﬁcient diagnostic protocol
designed to optimize the therapeutic ap-
proach and improve the prognosis in
these patients.
Theearlysuspicionofosteomyelitisis
essentially clinical and is based on detec-
tion of the presence of signs and symp-
tomsofinfection,althoughmanypatients
havenotypicallocalsigns(4).Eveninthe
absence of clinical signs, most infected
chronic ulcers of the diabetic foot have
underlying osteomyelitis. A lack of clini-
cal signs can lead to a delay in diagnosing
the initial stages of infection (5).
The plain X-ray is not useful for de-
tectingboneinfectionintheﬁrst2weeks.
Bone abnormalities can generally not be
seen until bone mineral density drops to
35–50% of that of normal adjacent bone
(6,7).Moreover,subtlechangesattheon-
set of osteomyelitis are not easily distin-
guished from other changes that occur in
the feet of these patients due to their neu-
ropathy or peripheral vascular disease
(8).
The probe-to-bone (PTB) test is rou-
tinely performed to detect, using a blunt
instrument, palpable bone through the
ulcer, indicating osteomyelitis (9). How-
ever, this test has been validated only in a
few previous studies, and there is cur-
rently no consensus on a standardized
protocol for the clinical diagnosis of os-
teomyelitis (10). The present study pro-
vides data on the validity of the clinical
tests most frequently used to detect this
disease.
RESEARCH DESIGN AND
METHODS— This observational, de-
scriptive study with prospective collec-
tion of data was conducted in patients
with type 1 or 2 diabetes who attended
the Diabetic Foot Clinic of the University
Podology Clinic, Universidad Com-
plutense de Madrid (Spain) because of a
foot ulcer.
OvertheperiodMay2006toNovem-
ber 2008, we treated 210 foot lesions in
diabetic patients. Of these lesions, 132
with clinical suspicion of infection were
selected as the study sample, of which
105(79.5%)wereﬁnallydiagnosedasos-
teomyelitis. Infection was recorded ac-
cording to the presence of clinical signs
and symptoms and a positive soft tissue
culture result. Once infection of the ulcer
had been established, presumptive osteo-
myelitis was diagnosed by plain radiogra-
phy and a clinical examination.
Patients were enrolled if they had a
single ulcer of neuropathic or neuroisch-
emic etiology below the ankle, there was
suspicion of bone infection according to
clinicalsignsandsymptomsandthediag-
nostic tests standardized in the protocol
used at our center (ulcer specimen cul-
ture, radiography, and PTB), if they had
undergone surgery for acute osteomyeli-
tis, or if after adequate local or antibiotic
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solve. Patients were excluded if they had
critical ischemia according to the classiﬁ-
cation of Fontaine et al. (11) or were due
for an operation that was unrelated to a
diagnosisofosteomyelitis.Thestudypro-
tocol was approved by our institutional
review board.
A neuropathic ulcer was deﬁned as a
full-thickness skin defect produced, in
the absence of ischemia, as the conse-
quenceoflossofprotectivesensationorof
a deformity due to a motor neuropathy,
sometimes aggravated by autonomic al-
terations. Callus is observed covering the
lesion or at its margins, and these ulcers
usually bleed easily. Neuropathic ulcers
often appear at points of sustained low
pressure or shear over a bony
prominence.
A neuroischemic ulcer is a full-
thickness skin wound whose underlying
cause is both peripheral neuropathy and
peripheral arterial disease. Despite isch-
emia, symptoms may be absent. The
wound base is ulcerous, sphacelated, or
necrotic. Bleeding is absent or only slight.
Neuroischemic ulcers often appear in the
dorsal and lateral zones of the foot as the
consequence of a small traumatic injury
or shear.
Neuropathy was diagnosed by exam-
ining10sitesonthefootusingaSemmes-
Weinstein monoﬁlament 5.07 10 g
(Sensiﬁl-Novalab Ibe ´rica, Madrid, Spain)
and a Horwell 997 neurotensiometer
(Sensiﬁl-NovalabIbe ´rica)(12,13).Vascu-
lar involvement was deﬁned as an ankle-
arm index 0.8 (14), transcutaneous
oxygen tension (TcPo2) (using a TCM4
transcutaneous monitor; Radiometer
Medical, Brønshøj, Denmark) 30
mmHg (15), and lack of a dorsal pedal
and posterior tibial pulse (14).
Wound infection was clinically de-
ﬁnedaccordingtothecriteriaoftheInter-
national Working Group on the Diabetic
Foot(IWGDF)(16)asthepresenceoftwo
or more signs and symptoms of local in-
ﬂammation or systemic signs of infection
of no other apparent cause, along with a
purulent exudate. In addition, we also
looked for speciﬁc signs such as necrosis,
delayed wound healing, foul odor, and
bone exposure.
Softtissuespecimensforculturewere
obtained after brief cleaning of the ulcer
surfacewithsalineandsterilegauze.Sam-
ples of exudate were obtained by rubbing
thesurfacewithasterilecottonswab,and
deeptissuesampleswereobtainedusinga
no. 10 or 15 scalpel blade (CE 0086;
Swann-Morton, Shefﬁeld, U.K.). Speci-
mens were transferred to a sterile vessel
containing transport medium (CE 0344;
Copan Innovation, Brescia, Italy) and
submitted to the microbiology laboratory
for culture.
We assessed the ulcers according to
the classiﬁcation schemes of Wagner and
Texas(16,17)torecordtheextensionand
depth of all soft tissue lesions and detect
any evidence of bone infection. In addi-
tion, a PTB test was performed in all pa-
tients using a blunt, sterile, metal surgical
instrument to gently explore the ulcer.
Thetestresultwasscoredpositivewhena
hard substance assumed to be bone was
palpated accompanied or not by deep si-
nustracts.ThePTBwasalwaysconducted
by the same experienced podiatrist.
Allofthepatientswithdiabeticulcers
underwent plain radiography to obtain
dorsoplantar,lateral,andobliqueviewsof
both feet for assessment of possible bone
alterationsproducedbythelesion.Osteo-
myelitis was suspected when one or more
of the following radiographic signs were
observed: periosteal elevation, cortical
disruption, medullary involvement, oste-
olysis, and sequestra (segments of ne-
crotic bone separated from living bone by
granulation tissue).
Finally, based on the results of the
clinical examination, soft tissue culture,
PTB, and plain X-ray, patients with a di-
agnostic suspicion of osteomyelitis were
subjectedtoabonetissuebiopsyobtained
by conservative surgery. During surgery,
we ﬁrst removed all nonviable infected
soft tissue and then excised all of the af-
fected bone, obtaining a representative
bone sample for subsequent histopatho-
logical analysis. The bone biopsy speci-
mens were introduced in a sterile
recipientcontaining10%bufferedforma-
lin solution and transported to the patho-
logical anatomy laboratory within 48 h,
where they were immediately processed
and examined. The histological criteria
considered diagnostic of osteomyelitis
were inﬂammatory cell inﬁltrate mostly
composed of lymphocyte cells, plasma
cells, neutrophils within spongy and cor-
tical bone; bone necrosis; and reactive
bone neoformation possibly accompa-
nied by prominent periosteal bone prolif-
eration (18). We used the results of the
bone biopsy to conﬁrm the diagnosis of
osteomyelitis.
RESULTS— The prevalence of osteo-
myelitis in the 132 patients with clinical
suspicion of infection included in this
study was 79.5% (105 patients). Each of
these patients had a single ulcer. Of the
ulcers, 59% were classiﬁed as neuro-
pathic and 41% were classiﬁed as neu-
roischemic. The mean  SD duration of
diabetes was 15.6  9.5 years, blood glu-
cose was 161.4  60.3 mg/dl, and A1C
was7.91.9%.Thefollowingcomplica-
tions of diabetes were recorded: diabetic
retinopathy in 68 patients (51.5%), dia-
betic nephropathy in 27 patients
(20.5%), hypertension in 94 patients
(71.2%),strokein62patients(47%),car-
diovascular problems in 56 patients
(42.4%), prior ulcers in 65 patients
(49.2%),andpriorconservativelowerex-
tremity amputation in 48 patients
(36.4%).
The etiopathogenic characteristics of
the ulcers were lack of pedal pulses in 33
patients (25%), a positive monoﬁlament
test in 100 patients (75.8%), and vibra-
tion sensitivity in 121 patients (91.7%);
the ankle-arm index was 0.91  0.3 and
TcPO2 was 34.2  14 mmHg. In 124 pa-
tients (93.9%), the ulcer was classiﬁed as
WagnergradeIII,in5.3%asgradeII,and
in 0.8% as grade IV. According to Texas
classiﬁcation, the ulcers in 73 patients
(55.3%) were type IIIA and in 41 patients
(31.1%) they were type IIIB; types IA and
IIIC were less frequently recorded, and
each appeared in only 1 patient (0.8%).
In 75 patients (56.8%), the exudate
from the ulcer was serous, in 32 patients
(24.2%), there was no exudate, in 18 pa-
tients (13.6%), the exudate was purulent,
in 5 patients (3.8%), it was sanguinous,
and in 2 patients (1.5%) it was serosan-
guinous. In 98.2% of the patients, the ul-
cers appeared on the forefoot. Most of
these ulcers appeared on the middle toes
(second,third,andfourth)(28.7%)orthe
undersideofthesecond,third,andfourth
metatarsals (27.2%). The least frequent
locations were over the scaphoid (0.9%)
and cuboid (0.9%) bones.
The mean time of ulcer duration was
44 weeks, the median being 16 weeks
(range 1–74 weeks). When we examined
ulcer duration according to the results of
the different diagnostic methods, in pa-
tients in whom osteomyelitis was biopsy
proven, ulcer duration was 41.67 
75.52 weeks, and in those with a negative
biopsy result, it was 52.19  104.32
weeks (P  0.554). Corresponding ulcer
durationsinweeksrecordedforapositive
versus a negative test result, respectively,
were PTB 41.15  74.19 vs. 56.48 
112.74 (P  0.417), ulcer specimen cul-
ture 45.83  85.14 vs. 33.19  62.55
Morales Lozano and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 10, OCTOBER 2010 2141(P  0.519), radiography signs 42.08 
72.97 vs. 55.59  129.61 (P  0.528),
and clinical signs 44.26  89.51 vs.
42.83  62.99 (P  0.926).
Table 1 shows the sensitivity, speci-
ﬁcity, positive and negative predictive
values, and positive and negative likeli-
hood ratios obtained for the four tests.
Test efﬁciencies (percentage of patients
correctly diagnosed as positive or nega-
tive) were PTB 93.89% (88–99.1%), ul-
cer specimen culture 71.97% (63.4–
79.7%), radiographic signs 75.76%
(67.4–82.6%), and clinical signs 59.09%
(50.2–67.4%). To try to improve the ca-
pacity for diagnosing osteomyelitis, we
assessed the use of two of the clinical di-
agnostic methods compared with bone
histology and found that only when the
PTB test was one of the two methods was
the result signiﬁcant. Thus, the pair of
methods, clinical signs plus PTB, showed
a sensitivity of 64.8%, speciﬁcity of
77.8%, positive predictive value (PPV) of
91.9%, and negative predictive value
(NPV) of 36.2% (P0.001,0.298); for
radiography signs plus PTB the values re-
corded were sensitivity 88.6%, speciﬁcity
66.7%, PPV 91.2%, and NPV 60% (P 
0.001,  0.530); and for culture plus PTB
they were sensitivity 84.8%, speciﬁcity
77.8%,PPV93.8%,andNPV56.8%(P
0.001,  0.550).
Likewise, when we assessed the com-
bined use of three or four of the methods,
a signiﬁcant result was only obtained
when the PTB test was included. Thus,
the methods clinical signs plus radiogra-
physignsplusPTBshowedasensitivityof
60.9%, speciﬁcity of 85.2, PPV of 94.1%,
and NPV of 35.9% (P  0.001,  0.306);
for clinical signs plus culture plus PTB,
the values recorded were sensitivity 61%,
speciﬁcity 85.1%, PPV 94.1%, and NPV
35.8%(P0.001,0.300),andforclin-
ical signs plus radiography signs plus cul-
ture plus PTB, they were sensitivity
52.4%, speciﬁcity 85.2%, PPV 93.2%,
and NPV 31.5% (P  0.001,  0.230).
Finally, a multivariate analysis was
performed to see whether we could im-
provethediagnosisofosteomyelitisofthe
132 ulcers including the six variables:
clinical signs of infection, radiographic
signsofosteomyelitis,ulcerspecimencul-
ture, PTB test, and ulcer type (neuroisch-
emic/neuropathic) and duration. The
results of this analysis are presented as a
decision tree (Fig. 1).
The test revealed by this analysis as
most accurate was the PTB with a PPV of
94.5%. According to the decision tree, a
correct diagnosis was made in 98.4% of
theneuropathiculcersvs.88%oftheneu-
roischemic ulcers. The correlation be-
tween ulcer duration and risk of having
osteomyelitis was only signiﬁcant for the
neuroischemic ulcers such that 100% of
ulcers 9 weeks old were positive for
osteomyelitis.
CONCLUSIONS — In this study we
sought to provide data on the validity of
the tests used in current clinical practice
to diagnose chronic osteomyelitis in dia-
betic foot ulcers. There is still much con-
troversy regarding the best way to detect
bone infection in patients with diabetes,
andthereisalsoconfusionaboutwhichis
the most efﬁcient treatment (19). Al-
thoughmostresearchersconsiderthatthe
histopathological study of bone speci-
mens is the criterion standard for diag-
nosing osteomyelitis (20), this method is
notsystematicallyusedbecauseclinicians
feelthatsurgicallyobtainingbonetissueis
anaggressiveprocedureandputspatients
at risk. Moreover, qualiﬁed medical staff
are needed to undertake the surgical
procedure.
Few studies have validated the use of
clinicalsignsasadiagnostictoolforinfec-
tion of the diabetic foot. Cutting and
White (21) and Gardner et al. (22) per-
formed a series of studies on chronic foot
ulcers,buttheirpatientshaddifferentsys-
temic diseases including diabetes. Our
ﬁndings indicate that assessment of clini-
cal signs of infection in diabetic patients,
although valid, provides limited informa-
tionforapromptdiagnosisofosteomyeli-
tis. There is an obvious need for a more
detailed and precise deﬁnition of clinical
indicators in chronic diabetic ulcers.
Our results indicate that the plain ra-
diograph was a sensitive test because it
wasabletoidentify89%oftheunaffected
patients, yet it was poorly speciﬁc, as 32
ulcers were incorrectly diagnosed. In ad-
dition,therewaspooragreementbetween
the results of this test and those of bone
histology(0.136,P0.104).Theseob-
servations suggest that despite being an
inexpensive and quick test, it is of little
use for the prompt diagnosis of osteomy-
elitis in the diabetic foot. For greater di-
agnostic efﬁciency, the method would
have to be combined with other imaging
techniques. Prior studies have reported
similar results but in very small popula-
tions such that their reliability is low
(7,8).
The detection of an infected ulcer
prompts the suspicion of a contiguous in-
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ture of specimens from an ulcer is a valid
test, but the low speciﬁcity observed here
limits its use for the timely diagnosis of
osteomyelitis even when combined with
other tests. Microbiological cultures often
inducediagnosticerrorsbecausethesam-
ple is not properly obtained or because
the patient is receiving antibiotic treat-
ment (23). In addition, the performance
ofmicrobiologicalculturedependsonthe
quality of the sample and on an adequate
transport medium. A further drawback of
the culture method is that results are not
available for 3 or 4 days, and this delay in
conﬁrming the diagnosis could lead to
progression to osteomyelitis or, in more
serious cases, to the need for amputation.
Since its introduction, the PTB test
has been extensively used to evaluate di-
abetic patients with foot ulcers. Despite
this, to date only three studies have vali-
dated the use of this technique for the
early diagnosis of osteomyelitis in the di-
abeticfoot(9,20,24).Thedifferentresults
obtained by Grayson et al. (9) and Shone
et al. (24) may be attributed to the differ-
ent pretest probabilities of osteomyelitis
because their study populations differed
and also to the fact that not all patients
underwent the same test to conﬁrm the
diagnosis of osteomyelitis, making it dif-
ﬁcult to directly compare the ﬁndings of
the studies. Lavery et al. (20) conducted a
microbiology study of bone specimens in
each of their patients, and these authors
admitted that one of the limitations of
their study was that osteomyelitis was not
conﬁrmed by bone histology. Our study
differs from this last study in that it was
performed in the same foot clinic by the
same podiatrists. The inter-rater reliabil-
ity of the PTB test is also a factor to con-
sider as there are no published data
addressing this issue. The diagnostic
characteristics of the PTB test reported by
these authors and the values obtained
here are compared in Table 2.
According to some authors, the time
of ulcer duration is directly related to the
risk of osteomyelitis (25). However, we
were unable to correlate the presence of
infectionwithulcerduration(P0.554).
The number of patients in whom bone
Figure 1—The decision tree displays the results of a probabilistic analysis in a way that helps the clinician choose between the different diagnostic
tests.Thevariablesenteredintheanalysiswerebonehistologyasthedependentvariableandclinicalsignsofinfection,ulcerculture,X-ray,PTBtest,
neuropathic/neuroischemic ulcer, and ulcer duration as independent variables. The tests or conditions providing a signiﬁcant result in relation to
another test or condition appear in bold.
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(79.5%),andmeanulcerdurationwas42
weeks, compared with a mean of 52
weeks for a negative biopsy results. We
attribute this apparent discrepancy to the
wide dispersion of data, as ulcer duration
ranged from 1 to 75 weeks.
In our study population, the preva-
lence, or pretest probability, of osteomy-
elitis was high at 79.5% because most
patients examined at our clinic are re-
ferred from other health centers such that
most have a long duration ulcer. This ﬁg-
ure cannot be translated to general infec-
tions of the diabetic foot. Moreover, the
prevalence is probably higher in an out-
patientthaninahospitalsettingsuchthat
it is difﬁcult to make comparisons. A fur-
ther factor to consider is that almost half
of our patients (49.2%) had had prior ul-
cers, and many had undergone prior con-
servative foot amputations (36.4%).
These are considered risk factors for reul-
ceration and osteomyelitis. Although we
are aware that not all podiatrists direct a
patient with chronic osteomyelitis to sur-
gery, the philosophical basis to which we
subscribe is early surgical treatment, pri-
oritizingpreservationsoasnottoalterthe
foot’s biomechanics and avoiding major
amputations.
Of all the tests examined here, the
PTB test was the best at predicting the
biopsy results and was especially efﬁcient
for neuropathic ulcers (98.4% correctly
diagnosed vs. 88% for neuroischemic ul-
cers). This ﬁnding may be clearly seen in
the decision tree (Fig. 1).
One of the limitations of our study
was that we did not perform bone culture
as well as bone histology to conﬁrm the
diagnosisofosteomyelitis.Thisisbecause
specimensforculturecouldnotalwaysbe
obtained since the bone excised during
surgery for histopathological analysis was
insufﬁcient in size for any further tests.
However, as for the soft tissue cultures,
the bone culture procedure has the draw-
back that false-negative results, especially
in patients receiving antibiotic therapy or
false-positive results (due to contamina-
tion), are sometimes produced. The
shortcomingofusinghistologicalchanges
as the diagnostic standard for osteomyeli-
tis is that these changes are still rather
poorly deﬁned.
We observed good agreement be-
tween the palpation of bone in the PTB
test and the presence of osteomyelitis.
Moreover, the early diagnostic perfor-
mance of the PTB was much improved
over that offered by clinical signs of infec-
tion, ulcer specimen culture, and a plain
radiograph. Despite an obvious need for
furthervalidations,aspartofourprotocol
and in our outpatient setting, we found
the results of the PTB test to be valid and
reliable. Moreover, its easy use, low cost,
and high efﬁciency make it a good com-
plementary test at any level of care for a
timely diagnosis of osteomyelitis in the
chronic ulcers that appear on the feet of
diabetic patients.
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